Joseph Bradfield, M.D.
Otolaryngic Allergy Physician in Winter Haven, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 151 in Otolaryngic Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Joseph Bradfield, M.D. reported a CMS MIPS final score of 87.6/100 - above the 83.5 national average - and filed 227 Medicare Part D claims in 2024.
- 87.6/100
- MIPS score · +4 vs avg
- 227
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥52nd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Joseph Bradfield, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1841218153), first enumerated 07/17/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 227 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 87.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Joseph Bradfield, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1841218153 · Otolaryngic Allergy Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1841218153
- ENUM-LEGACY 2006
- TAX-TRACE 151
- MIPS-ABOVE 87.6/100
- RX-LIGHT 227
- BOOK-THIN 15 in Florida
- PHOTO-FINISH Alexander Keszeli, D… · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- David Armstrong,…
David Armstrong, MD
87.2 MIPS pts
- Bradfield · this…
Bradfield · this provider
87.6 MIPS pts
- Alexander Keszel…
Alexander Keszeli, D.O.
87.7 MIPS pts
- Michael Callahan…
Michael Callahan, M.D.
87.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Joseph Bradfield, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
88 ≥ 52nd percentile 52% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Joseph Bradfield, M.D. sits
This provider among otolaryngic allergy physician peers
Across the 54 otolaryngic allergy physician providers who report both Medicare Part D prescribing and a MIPS quality score, Joseph Bradfield, M.D. writes more Part D claims than 17% of them and scores higher on MIPS quality than 46% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one otolaryngic allergy physician peer from a representative sample of 53; the gold marker is Joseph Bradfield, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Joseph Bradfield, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Joseph Bradfield, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Otolaryngic Allergy Physician compares to other specialties among Florida providers
Otolaryngic Allergy Physician ranks #421 among Florida's specialties (0% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Otolaryngic Allergy Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Joseph Bradfield, M.D.'s 2023 MIPS final score plotted against the Otolaryngic Allergy Physician national average
- MIPS Final Score
- 87.6/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Otolaryngic Allergy Physician US NPIs
87.6/100 MIPS final score - 4.1 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Otolaryngic Allergy Physician. Quality dim: 82.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1841218153 |
|---|---|
| Specialty | Otolaryngic Allergy Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/17/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Joseph Bradfield, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1841218153 is the unique 10-digit identifier CMS uses to link Bradfield across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Joseph Bradfield, M.D.. To verify Joseph Bradfield, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 387.567
- Total Day Supply
- 11,035
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.64
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Joseph Bradfield, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluticasone Propio…
Fluticasone Propionate
62 claims
- Ipratropium Bromide
Ipratropium Bromide
37 claims
- Montelukast Sodium 24
Montelukast Sodium
24 claims
- Famotidine 19
Famotidine
19 claims
- Fluocinolone Aceto… 15
Fluocinolone Acetonide Oil
15 claims
- Dupixent Syringe 14
Dupixent Syringe
14 claims
- Hydroxyzine Hcl 13
Hydroxyzine Hcl
13 claims
- Azelastine Hcl 11
Azelastine Hcl
11 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 62 |
| Ipratropium Bromide | 37 |
| Montelukast Sodium | 24 |
| Famotidine | 19 |
| Fluocinolone Acetonide Oil | 15 |
| Dupixent Syringe Dupilumab | 14 |
| Hydroxyzine Hcl | 13 |
| Azelastine Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngic Allergy Physician Overview
How Joseph Bradfield, M.D. fits within the Otolaryngic Allergy Physician landscape nationally.
Joseph Bradfield, M.D.'s 227 claims are below the specialty average of 768.
Nationwide Otolaryngic Allergy Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bradfield, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (87.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngic Allergy Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Bradfield.
One of 15 Otolaryngic Allergy Physician providers enrolled in Florida, 5 are shown here.
Compare Otolaryngic Allergy Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Joseph Bradfield, M.D.'s specialty? ▼
How much does Joseph Bradfield, M.D. prescribe under Medicare Part D? ▼
What is Joseph Bradfield, M.D.'s Medicare quality score? ▼
Where is Joseph Bradfield, M.D. located? ▼
What is Joseph Bradfield, M.D.'s NPI number? ▼
How many Otolaryngic Allergy Physician providers are there in the US? ▼
What drugs does Joseph Bradfield, M.D. prescribe most often? ▼
Does Joseph Bradfield, M.D. accept Medicare? ▼
How can I verify Joseph Bradfield, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.